CAMBRIDGE, Mass. (AP) _ LogicBio Therapeutics Inc. (LOGC) on Tuesday reported a loss of $7.7 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of 34 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
LogicBio Therapeutics shares have risen 39% since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LOGC at https://www.zacks.com/ap/LOGC